Neurocrine Biosciences Inc. logo

Neurocrine Biosciences Inc. (NB3)

Market Closed
17 Jul, 20:00
XSTU XSTU
149. 05
-0.85
-0.567%
- Market Cap
63.27 P/E Ratio
- Div Yield
200 Volume
2.29 Eps
149.9
Previous Close
Add Transaction
Day Range
147.35 149.95
Year Range
102.45 159.8
Want to track NB3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Neurocrine Biosciences Inc. logo
NB3 Neurocrine Biosciences Inc.
4 May 2026
1.73
-
Neurocrine Biosciences Inc. logo
NB3 Neurocrine Biosciences Inc.
11 Feb 2026
2.3
-
Neurocrine Biosciences Inc. logo
NB3 Neurocrine Biosciences Inc.
28 Oct 2025
2.07
-
Neurocrine Biosciences Inc. logo
NB3 Neurocrine Biosciences Inc.
30 Jul 2025
1.47
-
Neurocrine Biosciences Inc. logo
NB3 Neurocrine Biosciences Inc.
5 May 2025
-
-

NB3 Earnings Reports FAQ

What is the earnings per share (EPS) for NB3?

The current EPS is 2.29.

What is the company's earnings growth rate?

Neurocrine Biosciences Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Neurocrine Biosciences Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Neurocrine Biosciences Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for NB3 at this time, as Neurocrine Biosciences Inc has no recent EPS data to calculate it.